Beware of the Coated Aorta in Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography: A Specific Clue to the Diagnosis of Erdheim-Chester Disease in a Case of Brain and Orbital Lesions with Unknown Primary.

التفاصيل البيبلوغرافية
العنوان: Beware of the Coated Aorta in Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography: A Specific Clue to the Diagnosis of Erdheim-Chester Disease in a Case of Brain and Orbital Lesions with Unknown Primary.
المؤلفون: Kamaleshwaran KK; Department of Nuclear Medicine, PET/CT and Radionuclide Therapy, Kovai Medical Center and Hospital Limited, Coimbatore, Tamil Nadu, India., Ramkumar E; Department of Nuclear Medicine, PET/CT and Radionuclide Therapy, Kovai Medical Center and Hospital Limited, Coimbatore, Tamil Nadu, India.
المصدر: Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India [Indian J Nucl Med] 2023 Oct-Dec; Vol. 38 (4), pp. 381-383. Date of Electronic Publication: 2023 Dec 20.
نوع المنشور: Case Reports
اللغة: English
بيانات الدورية: Publisher: Medknow Country of Publication: India NLM ID: 8901274 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0972-3919 (Print) Linking ISSN: 09740244 NLM ISO Abbreviation: Indian J Nucl Med Subsets: PubMed not MEDLINE
أسماء مطبوعة: Publication: 2008 : Mumbai : Medknow
Original Publication: [Delhi] : Society of Nuclear Medicine, India
مستخلص: Erdheim-Chester disease (ECD) is a systemic histiocytosis that can involve several organs, with severity ranging from occult to life-threatening. The disease was first described by William Chester in 1930 after working with the Austrian pathologist Jakob Erdheim. Even today, a correct diagnosis of ECD often takes years, given the rarity and variable manifestations of ECD. We present a case of a 63-year-old female presenting with multiple brain lesions, sent for fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography to find primary, and it showed hypermetabolic right occipital brain lesion, right orbital lesion, and soft tissue around the arch of the aorta (coated aorta), and final histopathology of the brain lesion confirmed histiocytosis ECD.
Competing Interests: There are no conflicts of interest.
(Copyright: © 2023 Indian Journal of Nuclear Medicine.)
References: Indian J Radiol Imaging. 2021 Oct 06;31(3):729-734. (PMID: 34790325)
Am J Ophthalmol Case Rep. 2018 Jul 25;11:158-163. (PMID: 30094395)
J Nucl Med. 2018 May;59(5):774-779. (PMID: 29097410)
Rheumatology (Oxford). 2021 Feb 1;60(2):986-987. (PMID: 33527114)
Clin Exp Rheumatol. 2014 May-Jun;32(3):410-4. (PMID: 24428974)
Clin Nucl Med. 2014 Feb;39(2):170-7. (PMID: 23640213)
Am J Case Rep. 2022 Aug 16;23:e935885. (PMID: 35971309)
AJR Am J Roentgenol. 2004 Nov;183(5):1253-60. (PMID: 15505288)
Ann Clin Transl Neurol. 2020 Apr;7(4):497-506. (PMID: 32227455)
فهرسة مساهمة: Keywords: Brain lesions; Erdheim–Chester disease; coated aorta; fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography
تواريخ الأحداث: Date Created: 20240223 Latest Revision: 20240224
رمز التحديث: 20240224
مُعرف محوري في PubMed: PMC10880849
DOI: 10.4103/ijnm.ijnm_63_23
PMID: 38390541
قاعدة البيانات: MEDLINE
الوصف
تدمد:0972-3919
DOI:10.4103/ijnm.ijnm_63_23